A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus

Pristya Ramadhani, Bramantono Bramantono, Made Putra Sedana

Abstract


Progressive multifocal leukoencephalopathy (PML) is a rare but fatal disease leading to severe neurological impairments. PML is a clinical manifestation, which is usually associated with John Cunningham virus (JCV) infection. It is also correlated to malignancies that mainly include hematologic malignancies such as chronic lymphocytic leukemia (CLL). Until now, no specific treatment has been established for JCV-induced PML; therefore, the prognosis of this disease is poor.
We present a case of a 67-year-old woman who suffered from CLL with a chief complaint of seizure. Her clinical symptoms, results of brain MRI and biopsy were suggestive for the JCV-induced PML. The patient had received treatment using mefloquine at dose of 250 mg/day with no clinical improvement.

Keywords


progressive multifocal leukoencephalopathy (PML); John Cunningham virus; chronic lymphocytic leukemia (CLL)

References


Montserrat E, Moreno C. Chronic lymphocytic leukemia: a short overview. Ann Oncol. 2008;19:320-36.

Morrison VA. Infectious complications in patients with chronic lymphocytic leukemia, pathogenesis, spectrum of infection and approaches to prophylaxis. Clin Lymph Myeloma. 2009;9:365-70.

Bag AK, Cure JK, Chapman PR, et al. JC virus infection of the brain. Am J Neuroradiol. 2010;31:1564-76.

Shackelton LA, Rambaut A, Pybus O, et al. JC virus evolution and its association with human populations. J Virol. 2006;80:9928-33.

Saribas AS, Ozdemir A, Lam C, et al. JC virus-induced progressive multifocal leukoencephalopathy. Future Virol. 2010;5:313-23.

D’Souza A, Wilson J, Mukherje S, et al. Progressive multifocal leukoencephalopathy in chromic lymphocytic leukemia: A report of three cases and review of the literature. Clin Lymph Myeloma Leukem. 2010;10:E1–E9.

Da Silva RL. Spectrum of neurologic complications in chronic lymphocytic leukemia. Clin Lymph Myeloma Leukem. 2012;12:164-79.

Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-15.

Johnston BJ, Seftel M, Spencer BG. Chronic lymphocytic leukemia. In: editor Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber AD, Means TR, eds. Wintrobe’s clinical hematology. 12th edition. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 2214-45.

Sedana MP. New insight in management of chronic lymphocytic leukemia. Naskah lengkap Surabaya Hematologi Onkologi Medik Update-VIII (Surabaya HOM Update-VIII) medical management of cancer. In: Boediwarsono, Soebandiri, Soegianto, Ashariati A, Sedana MP, Ugroseno, eds. Surabaya; 2009. p. 200-6.

Shanafelt TD, Call TG. Current approach in diagnosis and management of chronic lymphocytic leukemia. Mayo Clin Proc. 2004;79:388-98.

Rotty WL. Leukemia limfositik kronik. In: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata M, Setiati S, eds. Buku ajar ilmu penyakit dalam. 5th edition. Jakarta: Interna Publishing; 2009. p. 1276-81.

Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukemia. Br Med Bull. 2008;7:49-62.

Bower JH, Hammack JE, McDonnell SK, et al. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology. 1997;48:407-12.

Jiang M, Abend J, Johnson S, et al. The role of polyomaviruses in human disease. Virology. 2009; 384:266-73.

Monaco M, Atwood W, Gravell M, et al. JC virus infectiojn of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol. 1996;70:7004-12.

Bofill-Mas S, Girones R. Role of the environment in the transmission of JC virus. J Neurovirol. 2003;9:54-8.

Hou J, Seth P, Major E. JC virus can infect human immune and nervous system progenitor cells: implication for pathogenesis. Polyomavirus and human disease advances in experimental medicine and biology. 2005;577:266-73.

La Rose G, Fratini M, Libera S, et al. Emerging and potentially emerging viruses in water environments. Ann Ist Super Sanita. 2012;48:397-406.

Engsig FN, Hansen A, Omland LH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: A nationwide cohort study. J Infect Dis. 2009; 199:77-83.

Zhang M, Li F, Rasper M, et al. Prolonged stability of progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia. J Clin Oncol. 2010;28:e503-e506.

Laubach J. Progressive Multifocal Leukoencephalopathy after therapy for chronic lymphocytic leukemia. Clin Leukem. 2009;3:E24-E26.

Pho MT, Ashok A, Alwood WJ. JC virus enter human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol. 2000;74:2288-92.

Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380-3.

Horger M, Beschorner R, Beck R, et al. Common and uncommon imaging findings in progressive multifocal leukonchephalopathy (PML) with differential diagnostic considerations. Clin Neurolog Neurosurg. 2012;114:1123-30.

Hou J, Major E. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host. J Neuro Virol. 2000; 6:s98-s100.

Calabrese L. A rational approach to PML for the clinician. Cleve Clin J Med. 2011;78:s38-41.

Focosi D, Kast R, Maggi F, et al. Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis. J Clin Virol. 2007;39:63-4.

Verma S, Cikurel K, Koralnik I, et al. Mirtazapine in progressive multifocal leukoenchepalopathy associated with polycythemia vera. J Infect Dis. 2007;196:709-11.

Gofton TE, Al-khotanil A, O’Farrell B, et al. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010;82:452-5.

Clifford DB, Nath A, Cinque P, et al. A study of Mefloquine treatment for progressive multifocal leukoencephalopathy: Result and exploration of predictors of PML outcomes. J Neuro Virol. 2013;19: 351-8.

Pelosini M, Focosi D, Rita F, et al. Progressive multifocal leukoencephalopathy report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol. 2007; DOL 10.1007/S D0277-007-0411-6.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Acta Medica Indonesiana